For some, sex drive plummets, creating frustration and relationship strain
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial
In June, Novo Nordisk ended its partnership with Hims & Hers, which had been announced just two months earlier, accusing the online marketplace of deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk. Shares of Wegovy manufacturer Novo Nordisk dropped more than 8% on Thursday to close at $43.34 Shares of Hims & Hers popped around 20% in pre-market trading following the announcement, but fell steadily throughout the day to close down 3.8% at $23.48 before falling another 1% in after-hours
The longer the gap in treatment, the bigger the jump in risk up to a 22 percent increase for heart attack, stroke and death after two years off GLP-1s, largely erasing the cardiovascular benefits gained during treatment
Association Between Metformin and Vitamin B12 Deficiency in Patients With Type 2 Diabetes